News for Healthier Living

Study Finds SGLT-2 Inhibitors Linked to Lower Risk of Diabetic Foot Nerve Damage

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared to those taking glucagon-like peptide-1 (GLP-1) receptor agonists.

January 5, 2026


January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025